Home › Funds › PAYDEN & RYGEL › CVS
PAYDEN & RYGEL position in CVS
CVS HEALTH CORP · Consumer Staples
PAYDEN & RYGEL reported holding 260,340 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$22.3M, representing 1.75% of its reported portfolio and ranking #15 among its reported holdings. PAYDEN & RYGEL has disclosed CVS holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PAYDEN & RYGEL's CVS position evolved
PAYDEN & RYGEL first disclosed a stake in CVS in Q3 2023 at 283,400 shares (US$19.8M). The position peaked in Q4 2023 at 319,000 shares, worth US$25.2M. Across 9 filings, PAYDEN & RYGEL increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 260,340 shares valued at US$22.3M — an increase of 41,640 shares quarter over quarter.. Notable position changes include a 42% trim in Q1 2024 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 283.40K | $19.79M | New |
| Q4 2023 | 319.00K | $25.19M | Add |
| Q1 2024 | 183.50K | $14.64M | Reduce |
| Q3 2024 | 99.90K | $6.28M | New |
| Q3 2025 | 261.50K | $19.71M | New |
| Q4 2025 | 260.20K | $20.65M | Hold |
| Q1 2026 | 213.10K | $15.30M | Reduce |
| Q2 2026 | 218.70K | $22.62M | Add |
| Q3 2026 | 260.34K | $22.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on PAYDEN & RYGEL
FAQ
How long has PAYDEN & RYGEL held CVS?
PAYDEN & RYGEL has disclosed CVS holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
What is PAYDEN & RYGEL's current position in CVS?
As of Q3 2026, PAYDEN & RYGEL holds 260.34K shares of CVS (CVS HEALTH CORP), valued at $22.31M, representing 1.75% of its reported portfolio and ranking #15.
Has PAYDEN & RYGEL been buying or selling CVS?
In the latest 13F filing (Q3 2026), PAYDEN & RYGEL increased its position in CVS. The position peaked in Q4 2023 at 319.00K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.